Stock Events

Stock Events

Fate Therapeutics (FATE) Q4 2023 Earnings

26FebConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.62

-0.48

-0.33

-0.19

Details

Expected EPS

-0.522208

Actual EPS

-0.45

Surprise EPS

0.07

Surprise Percent

+13.83%

Description

Fate Therapeutics (FATE) has reported earnings of -0.45 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.